Details for 2022173763

Up to date per 01.04.2026

Actions

Title / Product Name

MODIFIZIERTE NUKLEOSIDE, NUKLEOTIDE UND NUKLEINSÄUREN UND IHRE VERWENDUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022173763

EP Publication Number

4108671

E-Number

1743499

Language

PCT Number

Publication Date

28.12.2022 A

20.11.2024 B1

Registration Date

20.11.2024

AT Publication Date

15.12.2024

Application Date

03.10.2011

Registration Number

Priorities

01.10.2010

40441310 P

IPC

C07H 19/10 20060101AFI20240911BHEP

Maximum Duration of Protection

03.10.2031

Owner

ModernaTX, Inc.325 Binney Street Cambridge, MA 02142US

Representative

No representatives present

Inventor

Schrum, Jason P Watertown, MA 02472-2580US

Siddiqi, Suhaib Burlington, MA 01803US

Ejebe, Kenechi New York, NY 10029US

Information about Fees